Hospital Medicine

EGFR+

Questions discussed in this category

Would you hold osimertinib in a patient with a STEMI, and for how long?

1 Answer available

Papers discussed in this category

JACC CardioOncol, 2019 Dec 17

Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS).

Related Topics in Hospital Medicine